Trials / Completed
CompletedNCT00001381
A Phase I Trial Using Suramin to Treat Superficial Transitional Cell Carcinoma of the Bladder
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 18 (planned)
- Sponsor
- National Cancer Institute (NCI) · NIH
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
Patients with superficial transitional cell carcinoma of the bladder will be treated with intravesical suramin in a phase I dose escalating study. The toxicity of suramin administered in this fashion will be evaluated.
Detailed description
Patients with superficial transitional cell carcinoma of the bladder will be treated with intravesical suramin in a phase I dose escalating study. The toxicity of suramin administered in this fashion will be evaluated.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | suramin |
Timeline
- Start date
- 1994-03-01
- Completion
- 2000-12-01
- First posted
- 2002-12-10
- Last updated
- 2008-03-04
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00001381. Inclusion in this directory is not an endorsement.